Tuesday, December 1, 2015

Same Rx, Higher Prices. Why?

The Institute for Clinical & Economic Review 
The U.S. is the only industrialized nation in the world that has not established an assessment program to determine how drugs are covered and how the drug prices are set. The multi-faceted obstacles in determining the pricing of drugs are embedded within the current healthcare system laws (Medicare, the single largest payer for Rx, is prohibited from negotiating pricing of drugs with the pharmaceutical industry). Visit the ICER website for comparative effectiveness and other analyses.

No comments: